All Stories

  1. A yeast phenomic model for the influence of Warburg metabolism on genetic buffering of doxorubicin

    Article • Cancer & Metabolism, October 2019, Springer Science + Business Media

    Dr. John L Hartman

  2. A Humanized Yeast Phenomic Model of Deoxycytidine Kinase to Predict Genetic Buffering of Nucleoside Analog Cytotoxicity

    Article • Genes, September 2019, MDPI AG

    Dr. John L Hartman

  3. A humanized yeast phenomic model of deoxycytidine kinase to predict genetic buffering of nucleoside analog cytotoxicity

    Article • July 2019, Cold Spring Harbor Laboratory Press

    Dr. John L Hartman

  4. A yeast phenomic model for the influence of Warburg metabolism on genetic buffering of doxorubicin

    Article • January 2019, Cold Spring Harbor Laboratory Press

    Dr. John L Hartman

  5. Gene-nutrient interaction markedly influences yeast chronological lifespan

    Article • Experimental Gerontology, December 2016, Elsevier

    Dr. John L Hartman

  6. Ribosomal Stalk Protein Silencing Partially Corrects the ΔF508-CFTR Functional Expression Defect

    Article • PLoS Biology, May 2016, PLOS

    Dr. John L Hartman

  7. Long-range coupling between the extracellular gates and the intracellular ATP binding domains of multidrug resistance protein pumps and cystic fibrosis transmembrane conductance regulator channels

    Article • The FASEB Journal, November 2015, Federation of American Societies For Experimental Biology (FASEB)

    Dr. John L Hartman

  8. Yeast Phenomics: An Experimental Approach for Modeling Gene Interaction Networks that Buffer Disease

    Article • Genes, February 2015, MDPI AG

    Dr. John L Hartman

  9. Aging and energetics’ ‘Top 40’ future research opportunities 2010-2013

    Article • F1000Research, September 2014, Faculty of 1000, Ltd.

    Dr. John L Hartman, Ganesh Halade

  10. Conserved Allosteric Hot Spots in the Transmembrane Domains of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channels and Multidrug Resistance Protein (MRP) Pumps

    Article • Journal of Biological Chemistry, May 2014, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr. John L Hartman

  11. Phenomic Assessment of Genetic Buffering by Kinetic Analysis of Cell Arrays

    Article • January 2014, Springer Science + Business Media

    Dr. John L Hartman

  12. The SWI/SNF Chromatin Remodeling Complex Influences Transcription by RNA Polymerase I in Saccharomyces cerevisiae

    Article • PLoS ONE, February 2013, PLOS

    Dr. John L Hartman

  13. A yeast phenomic model for the gene interaction network modulating CFTR-ΔF508 protein biogenesis

    Article • Genome Medicine, December 2012, Springer Science + Business Media

    Dr. John L Hartman

  14. A Screen to Identify Small Molecule Inhibitors of Protein–Protein Interactions in Mycobacteria

    Article • Assay and Drug Development Technologies, June 2011, Mary Ann Liebert Inc

    Dr. John L Hartman

  15. Recursive expectation-maximization clustering: A method for identifying buffering mechanisms composed of phenomic modules

    Article • Chaos An Interdisciplinary Journal of Nonlinear Science, June 2010, American Institute of Physics

    Dr. John L Hartman

  16. Global analysis of phase locking in gene expression during cell cycle: the potential in network modeling

    Article • BMC Systems Biology, January 2010, Springer Science + Business Media

    Dr. John L Hartman

  17. Genomewide Analysis Reveals Novel Pathways Affecting Endoplasmic Reticulum Homeostasis, Protein Modification and Quality Control

    Article • Genetics, May 2009, Genetics Society of America

    Dr. John L Hartman

  18. Stringent Mating-Type-Regulated Auxotrophy Increases the Accuracy of Systematic Genetic Interaction Screens withSaccharomyces cerevisiaeMutant Arrays

    Article • Genetics, October 2008, Genetics Society of America

    Dr. John L Hartman

  19. Defining genetic interaction

    Article • Proceedings of the National Academy of Sciences, March 2008, Proceedings of the National Academy of Sciences

    Dr. John L Hartman

  20. Buffering of deoxyribonucleotide pool homeostasis by threonine metabolism

    Article • Proceedings of the National Academy of Sciences, July 2007, Proceedings of the National Academy of Sciences

    Dr. John L Hartman

  21. High Throughput Drug Screening for Human Immunodeficiency Virus Type 1 Reactivating Compounds

    Article • Assay and Drug Development Technologies, April 2007, Mary Ann Liebert Inc

    Dr. John L Hartman

  22. Accurate, precise modeling of cell proliferation kinetics from time-lapse imaging and automated image analysis of agar yeast culture arrays

    Article • BMC Systems Biology, January 2007, Springer Science + Business Media

    Dr. John L Hartman

  23. The case for strategic international alliances to harness nutritional genomics for public and personal health

    Article • British Journal Of Nutrition, November 2005, Cambridge University Press

    Dr. John L Hartman

  24. Systematic quantification of gene interactions by phenotypic array analysis

    Article • June 2004, Springer Science + Business Media

    Dr. John L Hartman

  25. Principles for the Buffering of Genetic Variation

    Article • Science, February 2001, American Association for the Advancement of Science

    Dr. John L Hartman

  26. Functional Reconstitutionin Situof 5-Hydroxytryptamine2c(5HT2c) Receptors with αqand Inverse Agonism of 5HT2cReceptor Antagonists

    Article • Journal of Biological Chemistry, September 1996, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr. John L Hartman

  27. Cystic fibrosis transmembrane conductance regulator mutations that disrupt nucleotide binding.

    Article • Journal of Clinical Investigation, July 1994, American Society for Clinical Investigation

    Dr. John L Hartman

  28. Affinity purification of insoluble recombinant fusion proteins containing glutathione-S-transferase

    Article • Biotechnology and Bioengineering, April 1992, Wiley

    Dr. John L Hartman

  29. Intrinsic anion channel activity of the recombinant first nucleotide binding fold domain of the cystic fibrosis transmembrane regulator protein.

    Article • Proceedings of the National Academy of Sciences, March 1992, Proceedings of the National Academy of Sciences

    Dr. John L Hartman